130 related articles for article (PubMed ID: 509808)
1. Procainamide acetylation and disposition in dialysis patients.
Nattel S; Ogilvie RI; Kreeft J; Sitar DS; Graham DN; Rangno RE; Dufresne LR; Barre PE
Clin Invest Med; 1979; 2(1):5-11. PubMed ID: 509808
[No Abstract] [Full Text] [Related]
2. [Oral administration of procainamide for ventricular arrhythmia. Plasma concentrations during use of tablets(Pronestyl) and a slow-release preparation (Porcainamide Durettes)].
Bliddal J
Ugeskr Laeger; 1976 Sep; 138(40):2425-33. PubMed ID: 968996
[No Abstract] [Full Text] [Related]
3. Cumulation of N-acetylprocainamide, an active metabolite of procainamide, in patients with impaired renal function.
Drayer DE; Lowenthal DT; Woosley RL; Nies AS; Schwartz A; Reidenberg MM
Clin Pharmacol Ther; 1977 Jul; 22(1):63-9. PubMed ID: 872496
[TBL] [Abstract][Full Text] [Related]
4. Use of procainamide in chronic ambulatory peritoneal dialysis: report of a case.
Kroboth PD; Mitchum K; Puschett JB
Am J Kidney Dis; 1984 Jul; 4(1):78-9. PubMed ID: 6204527
[TBL] [Abstract][Full Text] [Related]
5. [Serum concentrations of procainamide during treatment with ordinary and sustained-release tablets].
Henningsen P; Laursen HB; Christiansen BD; Moller J
Ugeskr Laeger; 1976 Sep; 138(40):2433-7. PubMed ID: 968997
[No Abstract] [Full Text] [Related]
6. Experiences on a sustained-release procainamide preparation.
Ruosteenoja R; Torsti P; Sothmann A
Curr Ther Res Clin Exp; 1973 Oct; 15(10):707-12. PubMed ID: 4201315
[No Abstract] [Full Text] [Related]
7. Dosage, plasms concentration and antiarrhythmic effect of procainamide in sustained-release tablets.
Arstila M; Katila M; Sundquist H; Anttila M; Pere E; Tikkanen R
Acta Med Scand; 1974 Mar; 195(3):217-22. PubMed ID: 4595254
[No Abstract] [Full Text] [Related]
8. Plasma levels of procaine amide after administration of conventional and sustained-release tablets.
Karlsson E
Eur J Clin Pharmacol; 1973 Dec; 6(4):245-50. PubMed ID: 4591151
[No Abstract] [Full Text] [Related]
9. Immediate-release and sustained-release procainamide: bioavailability at steady state in cardiac patients.
Vlasses PH; Rocci ML; Porrini KA; Greenspon AJ; Ferguson RK
Ann Intern Med; 1983 May; 98(5 Pt 1):613-4. PubMed ID: 6189438
[No Abstract] [Full Text] [Related]
10. Resin hemoperfusion for severe N-acetylprocainamide toxicity in patients with renal failure.
Raja R; Kramer M; Alvis R; Goldstein S; DeLosAngeles A
Trans Am Soc Artif Intern Organs; 1984; 30():18-20. PubMed ID: 6085435
[No Abstract] [Full Text] [Related]
11. The quantitative disposition of procainamide and N-acetylprocainamide in the rat.
Schneck DW; Grove K; Dewitt FO; Shiroff RA; Hayes AH
J Pharmacol Exp Ther; 1978 Jan; 204(1):219-25. PubMed ID: 619132
[TBL] [Abstract][Full Text] [Related]
12. Kinetics of procainamide in anuric patients undergoing chronic hemodialysis.
Goicoechea FJ; Bischel MD; Jelliffe RW
Proc Clin Dial Transplant Forum; 1973; 3():92-5. PubMed ID: 4806653
[No Abstract] [Full Text] [Related]
13. [Interaction of phenytoin with propranolol, procainamide and digoxin].
Halawa B
Pol Tyg Lek; 1985 Jul; 40(28):790-3. PubMed ID: 4059101
[No Abstract] [Full Text] [Related]
14. Ventricular ectopy.
Grauer K; Lopez LM; Curry RW; Kravitz L; Robinson JD; Sands CR
J Fam Pract; 1984 Dec; 19(6):731-3, 737, 741-2 passim. PubMed ID: 6209358
[No Abstract] [Full Text] [Related]
15. Conversion from intravenous procainamide to oral sustained release tablets in cardiac patients.
Kalin ML; Babich MF; Klinke WP; Hui WK
Can J Cardiol; 1990; 6(1):15-8. PubMed ID: 2310989
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic of procainamide in man.
Koch-Weser J
Ann N Y Acad Sci; 1971 Jul; 179():370-82. PubMed ID: 5285382
[No Abstract] [Full Text] [Related]
17. The clinical use of procainamide.
Miller RR; Greenblatt DJ
Am J Hosp Pharm; 1974 Sep; 31(9):889-91. PubMed ID: 4607729
[No Abstract] [Full Text] [Related]
18. Conventional and sustained-release procainamide: update on pharmacology and clinical use.
Anderson JL
Clin Ther; 1985; 7(5):618-40. PubMed ID: 3902240
[TBL] [Abstract][Full Text] [Related]
19. [The effects and pharmacokinetics of mexiletine in ventricular arrhythmia in maintenance hemodialysis patients].
Kuno T; Takahashi S; Hibiya K; Shimada A; Nagura Y; Takeuchi M; Hatano M
Nihon Jinzo Gakkai Shi; 1987 Aug; 29(8):1087-92. PubMed ID: 3694885
[No Abstract] [Full Text] [Related]
20. [Value of blood tests in procaine amide use (apropos of 188 tests in 36 patients)].
Chiche P; Benaim R; Lellouch A; Godard JP
Arch Mal Coeur Vaiss; 1972 Jul; 65(7):797-803. PubMed ID: 4633517
[No Abstract] [Full Text] [Related]
[Next] [New Search]
